Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 27, 2003
An appraisal of 18F-FDG PET imaging in post-therapy surveillance of uterine cancers: clinical evidence and a research proposal
T Belhocine
JBR-BTR : Organe De La Societe Royale Belge De Radiologie (SRBR) = Orgaan Van De Koninklijke Belgische Vereniging Voor Radiologie (KBVR)
|
June 17, 2003
[The value of emission computed tomography with 18 F-fluorodeoxyglucose (PET scan with 18FDG)]
T Belhocine
Rheumatology (Oxford, England)
|
April 23, 2004
The right place of 18FDG PET for the diagnosis of giant cell arteritis--a response to the article of Brodmann et al
T Belhocine
Revue Medicale De Liege
|
May 10, 2000
[Diagnosis of primary hyperparathyroidism: role of scintigraphy]
E Brasseur, J C Philips, T Belhocine, et al.
Physics in Medicine and Biology
|
August 6, 2008
Accuracy of quantitative reconstructions in SPECT/CT imaging
S Shcherbinin, A Celler, T Belhocine, et al.
Nuclear Medicine Communications
|
September 26, 2003
Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndrome)
J L Alberini, T Belhocine, R Hustinx, et al.
Revue Medicale De Liege
|
April 19, 2000
[18FDG-PET imaging of pancreatic adenocarcinoma]
F Daenen, R Hustinx, T Belhocine, et al.
Prostate Cancer and Prostatic Diseases
|
August 17, 2011
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature
G Bauman, T Belhocine, M Kovacs, et al.
Clinical Nuclear Medicine
|
August 17, 2001
A case of cerebral metastases of unknown origin: utility of F-18 FDG positron emission tomography to localize the primary tumor
T Belhocine, S Bolle, J L Alberini, et al.
Nuclear Medicine Communications
|
July 19, 2002
Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67
T Belhocine, J Foidart, P Rigo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 27, 2003
An appraisal of 18F-FDG PET imaging in post-therapy surveillance of uterine cancers: clinical evidence and a research proposal
T Belhocine
JBR-BTR : Organe De La Societe Royale Belge De Radiologie (SRBR) = Orgaan Van De Koninklijke Belgische Vereniging Voor Radiologie (KBVR)
|
June 17, 2003
[The value of emission computed tomography with 18 F-fluorodeoxyglucose (PET scan with 18FDG)]
T Belhocine
Rheumatology (Oxford, England)
|
April 23, 2004
The right place of 18FDG PET for the diagnosis of giant cell arteritis--a response to the article of Brodmann et al
T Belhocine
Revue Medicale De Liege
|
May 10, 2000
[Diagnosis of primary hyperparathyroidism: role of scintigraphy]
E Brasseur, J C Philips, T Belhocine, et al.
Physics in Medicine and Biology
|
August 6, 2008
Accuracy of quantitative reconstructions in SPECT/CT imaging
S Shcherbinin, A Celler, T Belhocine, et al.
Nuclear Medicine Communications
|
September 26, 2003
Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndrome)
J L Alberini, T Belhocine, R Hustinx, et al.
Revue Medicale De Liege
|
April 19, 2000
[18FDG-PET imaging of pancreatic adenocarcinoma]
F Daenen, R Hustinx, T Belhocine, et al.
Prostate Cancer and Prostatic Diseases
|
August 17, 2011
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature
G Bauman, T Belhocine, M Kovacs, et al.
Clinical Nuclear Medicine
|
August 17, 2001
A case of cerebral metastases of unknown origin: utility of F-18 FDG positron emission tomography to localize the primary tumor
T Belhocine, S Bolle, J L Alberini, et al.
Nuclear Medicine Communications
|
July 19, 2002
Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67
T Belhocine, J Foidart, P Rigo, et al.
Page
of 2